MOACM
KITE

Mutual of America Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Mutual of America Capital Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-38,093
Closed -$6.85M – 1230
2017
Q3 		$6.85M Sell
38,093
-600
-2% -$83.6K 0.11% 213
2017
Q2 		$4.01M Sell
38,693
-1,922
-5% -$157K 0.07% 463
2017
Q1 		$3.19M Buy
40,615
+11,524
+40% +$713K 0.06% 568
2016
Q4 		$1.3M Sell
29,091
-145
-0.5% -$7.11K 0.02% 959
2016
Q3 		$1.63M Buy
29,236
+13,000
+80% +$724K 0.03% 834
2016
Q2 		$812K Hold
16,236
– – 0.02% 1054
2016
Q1 		$745K Sell
16,236
-100
-0.6% -$4.84K 0.02% 1066
2015
Q4 		$1.01M Buy
16,336
+95
+0.6% +$6.69K 0.02% 987
2015
Q3 		$904K Buy
16,241
+3,600
+28% +$226K 0.02% 1006
2015
Q2 		$771K Buy
12,641
+7,400
+141% +$422K 0.02% 1077
2015
Q1 		$302K Buy
+5,241
New +$351K 0.01% 1133

Mutual of America Capital Management's KITE Position: Q4 2017 in Review

Mutual of America Capital Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 38,093 shares — an estimated $6.85M sold.

Mutual of America Capital Management first reported a position in KITE in Q1 2015 and held it in 11 quarters. The position peaked at $6.85M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Mutual of America Capital Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Mutual of America Capital Management sold 38,093 Kite Pharma, Inc. shares in Q4 2017, an estimated $6.85M.
  • Mutual of America Capital Management first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 11 quarters.
  • Mutual of America Capital Management's Kite Pharma, Inc. position peaked at $6.85M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Mutual of America Capital Management's 13F filing for Q4 2017, filed 31 Jan 2018.